Op0020: Immunogenicity of an adjuvant recombinant zoster vaccine in patients with rheumatoid arthritis treated with upadacitinib: 60-week results from a randomized substudy

Authors

K L. Winthrop
S K Penn
J Klaff
Y Liu
C García
E Mysler
Alvin Wells, Advocate Health - MidwestFollow
X Bu
N Khan
M Chen
A L Cunningham

Recommended Citation

Winthrop KL, Penn SK, Klaff J, et al. Op0020: Immunogenicity of an adjuvant recombinant zoster vaccine in patients with rheumatoid arthritis treated with upadacitinib: 60-week results from a randomized substudy. Annals of the Rheumatic Diseases. 2024/06/01/ 2024;83:80-81. doi:https://doi.org/10.1136/annrheumdis-2024-eular.763

Affiliations

Advocate Aurora Medical Group

Document Type

Abstract